Profil
George Gilbert Cloyd is currently the CEO of Ofgcgi and a board member at Research Bridge Partners.
He previously worked as the Chairman of The Ohio State University, Lumos Pharma Sub, Inc., and Chief Technology Officer at Procter & Gamble Co. He earned a doctorate degree from The Ohio State University in 1969.
Aktive Positionen von George Cloyd
| Unternehmen | Position | Beginn |
|---|---|---|
Research Bridge Partners /Venture Capital/
Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners invests in companies located in the United States. The firm focuses on a biomedical sector. It provides finance for seed stage capital requirements. | Direktor/Vorstandsmitglied | 01.01.2017 |
Ofgcgi | Vorstandsvorsitzender | 01.10.2015 |
Ehemalige bekannte Positionen von George Cloyd
| Unternehmen | Position | Ende |
|---|---|---|
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Vorsitzender | 01.01.2009 |
| PROCTER & GAMBLE COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2008 |
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes a novel treatment for the rare disease Creatine Transporter Deficiency | Vorsitzender | - |
Ausbildung von George Cloyd
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Procter & Gamble Co.
Procter & Gamble Co. Household/Personal CareConsumer Non-Durables Manufactures and sells fabric & home care products, diapers, baby wipes, tissues, toilet paper, hair, skin and personal care, toothbrushes, vitamins, supplements & razors | Consumer Non-Durables |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes a novel treatment for the rare disease Creatine Transporter Deficiency | Health Services |
Research Bridge Partners /Venture Capital/
Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners invests in companies located in the United States. The firm focuses on a biomedical sector. It provides finance for seed stage capital requirements. | Finance |
Ofgcgi |
















